1.
Fedders H, Alsadeq A, Schmäh J, Vogiatzi F, Zimmermann M, Möricke A, Lenk L, Stadt U zur, Horstmann MA, Pieters R, Schrappe M, Stanulla M, Cario G, Schewe DM. The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia. Haematologica [Internet]. 2017Oct.27 [cited 2026Nov.10];102(11):e438-e442. Available from: https://haematologica.org/article/view/8263